CAS: 134250-76-3; 1-(Methoxycarbonyl)Pyrrolidine-2-Carboxylic Acid

该化合物是一种有机化合物,其特点是具有两种碳酸基酸组和一个甲基酯功能组,具有两种碳酸基环结构的有机化合物,这种化合物一般看起来无色可粉黄黄色液体或固体,视其具体形式和纯度而定;在水和酒精等极地溶剂中可以溶解,这增强了其在各种化学应用中的用途;碳酸和酯功能允许多种反应,使其在有机合成中有用,特别是在制药和农用化学剂的制作方面.此外,其结构特征可能带来具体的生物活动,尽管对其生物特性的详细研究可能有限.与许多有机化合物一样,应当参考安全数据,以了解其处理,储存和潜在危害.

结构式图片

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2009099061-A1
    优先权日:2006-01-27
    标 题:Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics
    发明人:FOSS BENTE J; NADOLSKI GEOFFRY T; LOCKWOOD SAMUEL F
    权利人:FOSS BENTE J; NADOLSKI GEOFFRY T; LOCKWOOD SAMUEL F
    摘要:A method is described for synthesizing and administering carotenoid compounds with improved antioxidant characteristics. In some embodiments, extension or improvement of conjugation may be employed in structural modification of carotenoids. In other embodiments, reduction of ring/chain steric hindrance may improve the lambda max, and hence, the overall antioxidant capability, of particular compounds. In other embodiments, introduction and/or increase in synthetic handles for conjugation may improve the stoichiometric ratios of conjugating moieties to the polyene backbone. The methods may be used to improve natural and/or synthetic compounds for medicinal application in the treatment of disease.

    专利号:US-9265773-B2
    优先权日:2011-09-08
    标题 :Tetracyclic heterocycle compounds and methods of use thereof for the treatment of viral diseases
    发明人:MCCOMAS CASEY C; LIVERTON NIGEL J; HABERMANN JOERG; KOCH UWE; NARJES FRANK; LI PENG; PENG XUANJIA; SOLL RICHARD; WU HAO; PALANI ANANDAN; HE SHUWEN; DAI XING; LIU HONG; LAI ZHONG; LONDON CLARE; XIAO DONG; ZORN NICOLAS; NARGUND RAVI
    权利人:MCCOMAS CASEY C; LIVERTON NIGEL J; HABERMANN JOERG; KOCH UWE; NARJES FRANK; LI PENG; PENG XUANJIA; SOLL RICHARD; WU HAO; PALANI ANANDAN; HE SHUWEN; DAI XING; LIU HONG; LAI ZHONG; LONDON CLARE; XIAO DONG; ZORN NICOLAS; NARGUND RAVI; MERCK SHARP & DOHME; MSD ITALIA SRL
    摘要:The present invention relates to compounds of formula (I) that are useful as hepatitis C virus (HCV) NS5B polymerase inhibitors, the synthesis of such compounds, and the use of such compounds for inhibiting HCV NS5B polymerase activity, for treating or preventing HCV infections and for inhibiting HCV viral replication and/or viral production in a cell-based system.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Yamashita, M., Science of Synthesis, (2007) 30, 666.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知